April 27, 2015 writer

TSO3 to Disclose First Quarter 2015 Financial Results and Hold Annual General and Special Meeting of Shareholders on May 6, 2015

Quebec City, April 27, 2015 – TSO3 Inc. (“TSO3”) (TSX: TOS) will report first quarter (Q1) 2015 financial results, for the period ended March 31, 2015 via press release on Wednesday May 6, 2015. TSO3 will also hold its Annual General and Special Meeting of Shareholders at 10:30 A.M. (EDT) the same day.

The Annual General Meeting of Shareholders will be held at the McCord Museum, J. Armand Bombardier theater, 690 Sherbrooke West, Montréal (Québec) H3A 1E9  at 10:30 A.M. (EDT).

For those who are unable to attend in person, we invite you to listen to the live webcast of the Annual General and Special Meeting of Shareholders via CNW’s website at: http://www.newswire.ca/en/webcast/detail/1512631/1686383

The webcast will then be archived for a 90-day period.

About TSO3

Founded in 1998, TSO3’s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. It also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO3, visit the Company’s Web site at www.tso3.com.

The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

-30-

Back to Posts